# Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.

> **NCT02185131** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 16 (actual)

## Conditions studied

- Major Depressive Disorder
- Alcohol Use Disorder

## Interventions

- **DRUG:** Mirtazapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02185131
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185131, "Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02185131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*